Holen Sie sich die Stockscreener-App
0.1639
3.25%
-0.0055
Handel nachbörslich:
.16
-0.0039
-2.38%
Schlusskurs vom Vortag:
$0.1694
Offen:
$0.165
24-Stunden-Volumen:
5.30M
Relative Volume:
0.65
Marktkapitalisierung:
$7.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.88M
KGV:
-0.4498
EPS:
-0.3644
Netto-Cashflow:
$-9.98M
1W Leistung:
-13.74%
1M Leistung:
-17.31%
6M Leistung:
-83.21%
1J Leistung:
-97.05%
1-Tages-Spanne:
$0.16
$0.174
1-Wochen-Bereich:
$0.132
$0.3583
52-Wochen-Spanne:
$0.132
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Firmenname
Liminatus Pharma Inc
Sektor
Branche
Telefon
213-273-5453
Adresse
12611 HIDDENCREEK WAY, CERRITOS
Compare LIMN vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.1639 | 7.60M | 0 | -9.88M | -9.98M | -0.3644 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Liminatus Pharma Inc Aktie (LIMN) Neueste Nachrichten
Liminatus announces proposed merger with InnocsAI - The Pharma Letter
Liminatus Pharma notifies NASDAQ of impending delisting; plans to appeal - MSN
LIMN Should I Buy - Intellectia AI
Liminatus Pharma (LIMN) Faces Delisting from Nasdaq - GuruFocus
Liminatus Pharma (LIMN) Faces Nasdaq Delisting Notice Amid Compl - GuruFocus
Liminatus Pharma (LIMN) Plunges 31% as Support Level Approaches – Key Levels to WatchExpert Breakout Alerts - Newser
Liminatus Pharma receives Nasdaq delisting notice - TipRanks
Number of shareholders of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
LIMN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Liminatus Pharma (LIMN) Stock: Surges Ahead of Nasdaq Delisting Deadline - MEXC
Liminatus Pharma (LIMN) Stock: Nasdaq Delisting Warning Sparks Volatile Trading Session - Blockonomi
Liminatus Pharma (LIMN) Stock Jumps 31% Despite Looming Nasdaq Delisting Threat - MoneyCheck
Liminatus Pharma faces Nasdaq delisting after compliance failure By Investing.com - Investing.com Canada
Liminatus Pharma to be delisted from Nasdaq for failing market value rules, plans to appeal. - Pluang
Liminatus Pharma Announces Nasdaq Delisting Notification - lincolnjournal.com
Liminatus Pharma faces Nasdaq delisting after compliance failure - Investing.com
Liminatus Pharma, Inc. Receives Nasdaq Delisting Notice Following Non-Compliance with Market Value Requirements - Quiver Quantitative
Liminatus Pharma faces Nasdaq delisting after market value shortfall - Stock Titan
Liminatus Pharma Announces Nasdaq Delisting Notification - GlobeNewswire Inc.
Here are the top movers in Thursday's session. - ChartMill
Liminatus Pharma shares jump 79% after merger deal with InnocsAI announced - Pluang
Liminatus Pharma, Inc.Class A Common Stock (Nasdaq:LIMN) Stock Quote - The Chronicle-Journal
Most active stocks in Thursday's session - ChartMill
LIMN Stock Surges 39% as Liminatus Pharma Gains Momentum - Meyka
Liminatus Pharma: Deal Represents Transaction Value of About $320M >LIMN - Moomoo
Trending Stocks Today | Liminatus Pharma Surges 62.75% - Moomoo
Liminatus Pharma to merge with InnocsAI, expanding oncology cell therapy pipeline with $320M deal - Pluang
LIMN Stock Rises in Pre-Market on Liminatus InnocsAI Deal News - Bez Kabli
What's going on in today's pre-market session - ChartMill
Struggling Liminatus pays $320M in stock for CAR-T biotech InnocsAI - Fierce Biotech
Cancer biotech Liminatus lines up $320M deal for new cell therapies - Stock Titan
Top Premarket Gainers - Moomoo
Trending Stocks Today | Triller Group Soars 60.16% Pre-Market - Moomoo
Liminatus Pharma Is Trending Overnight — Here's Why LIMN Stock Surged Over 79% In After-Hours Session - Benzinga
Liminatus Pharma Announces Merger Agreement with InnocsAI LLC to Expand CAR-T Therapy Technologies - Minichart
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Liminatus Pharma to Acquire InnocsAI in Stock Deal, 1.6B Shares at $0.20 Plus CVRs - TradingView
Liminatus Pharma (LIMN) plans all-stock InnocsAI merger with CAR-T pipeline - Stock Titan
Liminatus Pharma, Inc. agreed to acquire InnocsAI LLC for approximately $320 million. - marketscreener.com
Liminatus Pharma 1Q 2026: Net loss $1.12M, Diluted EPS $(0.03) — 10-Q Summary - TradingView
Liminatus Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Liminatus Pharma (NASDAQ: LIMN) Q1 loss, going concern and Nasdaq listing risks - Stock Titan
TradingKey - TradingKey
Why Liminatus (LIMNW) is still under the radar (+33.11%) 2026-05-11Sector Leader - Newser
The key risks discussed in Liminatus Pharma (LIMN) earnings | LIMN QX Earnings: Liminatus Pharma Reports No Revenue, Pipeline FocusEarnings Revision Downgrade - Newser
LIMN QX Earnings: Liminatus Pharma Reports No Revenue, Pipeline FocusMacro Risk - newser.com
What Liminatus (LIMNW) disclosed about workforce costs | LIMNW: Liminatus Warrants Report No Earnings DataLiquidity Risk - Newser
Net current asset value per share of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
LIMNW Price History for Liminatus Pharma Warrants Stock - Barchart.com
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN
Is Liminatus (LIMNW) stock trending down today | Liminatus Posts No Financials, Pipeline Drives Warrant MovesHigh Growth - newser.com
Finanzdaten der Liminatus Pharma Inc-Aktie (LIMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):